Old Web
English
Sign In
Acemap
>
authorDetail
>
Naoki Fukazawa
Naoki Fukazawa
Chugai Pharmaceutical Co.
Medicine
Pharmacodynamics
Pharmacokinetics
Emicizumab
Immunology
4
Papers
404
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Anti-pruritic effect of nemolizumab in hemodialysis patients with uremic pruritus: a phase II, randomized, double-blind, placebo-controlled clinical study
2021
Clinical and Experimental Nephrology
Eriko Kinugasa
Ken Igawa
Hisaki Shimada
Morihiro Kondo
Satoshi Funakoshi
Naoki Imada
Noritomo Itami
Naoki Fukazawa
Ryoko Takubo
Yuichi Kawata
Hiroyuki Murota
Show All
Source
Cite
Save
Citations (3)
Factor VIII–Mimetic Function of Humanized Bispecific Antibody in Hemophilia A
2016
The New England Journal of Medicine
Midori Shima
Hideji Hanabusa
Masashi Taki
Tadashi Matsushita
Tetsuji Sato
Katsuyuki Fukutake
Naoki Fukazawa
Koichiro Yoneyama
Hiroki Yoshida
Keiji Nogami
Show All
Source
Cite
Save
Citations (240)
A first-in-human phase 1 study of ACE910, a novel factor VIII-mimetic bispecific antibody, in healthy subjects.
2016
Blood
Naoki Uchida
Takehiko Sambe
Koichiro Yoneyama
Naoki Fukazawa
Takehiko Kawanishi
Shinichi Kobayashi
Midori Shima
Show All
Source
Cite
Save
Citations (154)
Safety and Prophylactic Efficacy Profiles of ACE910, a Humanized Bispecific Antibody Mimicking the FVIII Cofactor Function, in Japanese Hemophilia A Patients Both without and with FVIII Inhibitors: First-in-Patient Phase 1 Study
2014
Blood
Midori Shima
Hideji Hanabusa
Masashi Taki
Tadashi Matsushita
Tetsuji Sato
Katsuyuki Fukutake
Naoki Fukazawa
Shingo Maisawa
Koichiro Yoneyama
Keiji Nogami
Show All
Source
Cite
Save
Citations (7)
1